ACHIEVING A BETTER CURE FOR CANCER MORE INFO CiMaas develops immunotherapy for cancer by optimally engaging the immune system. Read more about CiMaas Immunotherapy products Watch our video News CiMaas wishes our partners a very happy 2026 and we are looking forward to successful collaborations in achieving our common goals.January 1, 2026 CiMaas obtained another grant from LIOF for validation of its feeder cell technologyApril 9, 2025 CiMaas moves into new facilityDecember 3, 2024 TECHNOLOGY PIPELINE INVESTORS GENERAL PUBLIC
